Dr. Ayoub is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
543 Taylor Ave
Columbus, OH 43203Phone+1 614-293-4837Fax+1 614-293-3125
Education & Training
- SUNY Downstate Health Sciences UniversityFellowship, Nephrology, 2011 - 2013
- Zucker School of Medicine at Hofstra/Northwell at Staten Island University HospitalResidency, Internal Medicine, 2008 - 2011
- Lebanese University School of MedicineClass of 2005
Certifications & Licensure
- OH State Medical License 2014 - 2025
- American Board of Internal Medicine Nephrology
Clinical Trials
- A Study With Imlifidase in Anti-GBM Disease Start of enrollment: 2022 Dec 22
Roles: Contact
- Part 1 - A Clinical Trial in Patients With Frequently Relapsing and Steroid-Dependent Nephrotic Syndrome Start of enrollment: 2023 Jan 01
Roles: Contact
Publications & Presentations
PubMed
- 68 citationsCureGN Study Rationale, Design, and Methods: Establishing a Large Prospective Observational Study of Glomerular DiseaseLaura H. Mariani, Andrew S. Bomback, Pietro A. Canetta, Michael F. Flessner, Margaret E. Helmuth
American Journal of Kidney Diseases. 2019-02-01 - 21 citationsMolecular profiling of kidney compartments from serial biopsies differentiate treatment responders from non-responders in lupus nephritis.Samir V Parikh, Ana Malvar, Huijuan Song, John Shapiro, Juan Manuel Mejia-Vilet
Kidney International. 2022-10-01 - 44 citationsStaphylococcus Infection–Associated GN – Spectrum of IgA Staining and Prevalence of ANCA in a Single-Center CohortAnjali A. Satoskar, Sarah Suleiman, Isabelle Ayoub, Jessica Hemminger, Samir M. Parikh
Clinical Journal of the American Society of Nephrology. 2017-01-06
Press Mentions
- New Findings Add to Questions About Existence of Gouty NephropathyJanuary 13th, 2021
- Clinical Trials, Non-Drug Studies at the Ohio State University Wexner Medical Center Aim to Slow Kidney Disease ProgressionJanuary 24th, 2021
- New KDOQI Commentary of 2021 KDIGO Clinical Practice Guideline for Glomerular Diseases PublishedJune 23rd, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: